HotCopper on MSN
Telix jumps on maiden Chinese application for prostate imaging agent, but short selling increasing
Telix Pharma’s (ASX:TLX) got the Chinese market locked in its sights with a maiden application for Illuccix, a prostate cancer imaging agent, now lodged with (and accepted by) the National Medical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results